Phase 1 Study of ACE-083 in Healthy Subjects
Clinical trial NCT02257489 · COMPLETED
Trial details
- NCT number
- NCT02257489
- Sponsor
- Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2016-03-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.